烟台北方制药

Yantai Northern Pharmaceutical Co., Ltd. is a specialized pharmaceutical manufacturer based in Yantai, Shandong Province, China, and operates as a key subsidiary of Guizhou Yibai Pharmaceutical. The company focuses on the research, development, and large-scale production of chemical drugs and traditional Chinese medicine (TCM) formulations, with a strong emphasis on oncology and cardiovascular health. Its product portfolio includes notable treatments such as Lofexidine Hydrochloride for opioid withdrawal and various TCM-based injectables. Yantai Northern Pharmaceutical maintains modern, GMP-certified manufacturing facilities for multiple dosage forms, including large and small volume injections, tablets, and capsules. As a core production hub for its parent organization, the company plays a vital role in the supply chain for several major therapeutic products in the Chinese domestic market.